Immunogold labeling for the diagnosis of leukemia by transmission and scanning electron microscopy

E de Harven1, D Soligo, H Christensen

  • 1Department of Pathology, University of Toronto, Canada.

Scanning Microscopy
|January 1, 1995
PubMed

Insights

Immuno-electron microscopy aids leukemia diagnosis in adults. CD103 confirms hairy cell leukemia, but CD61 findings suggest circulating megakaryocythemia, not true megakaryoblastic leukemia (M7).

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Diagnosing leukemia in adults can be challenging, especially when bone marrow sampling is difficult.
  • Peripheral blood leukocyte (PBL) analysis offers an alternative diagnostic avenue.

Purpose of the Study:

  • To evaluate the utility of immuno-electron microscopy in diagnosing leukemia subtypes, specifically hairy cell leukemia and megakaryoblastic leukemia (M7).
  • To differentiate between true megakaryoblastic leukemia and other conditions with megakaryocytic features.

Main Methods:

  • Indirect immunogold labeling using B-ly7 monoclonal antibody (CD103) for hairy cell leukemia.
  • Immunogold labeling for GpIIIa platelet glycoprotein (CD61) in suspected megakaryoblastic leukemia cases.
  • Electron microscopy examination of peripheral blood leukocytes.

Main Results:

  • CD103 labeling confirmed hairy cell leukemia diagnoses.
  • CD61-positive cells in suspected M7 cases exhibited extensive megakaryopoietic differentiation, including alpha granules and demarcation membranes.
  • These findings indicated circulating megakaryocythemia rather than true megakaryoblastic leukemia in most cases.

Conclusions:

  • Immuno-electron microscopy is valuable for leukemia diagnosis, particularly when bone marrow access is limited.
  • CD61 expression in peripheral blood cells may indicate megakaryocythemia, necessitating careful re-evaluation of megakaryoblastic leukemia (M7) diagnoses.
  • Distinguishing between M7 and other myeloproliferative disorders with megakaryocytic features is crucial for accurate patient management.